We are live on
!
Find out more
HC
Henshaw Capital Portfolio holdings
AUM
$3.07B
Turnover
11.76%
1-Year Est. Return
40.85%
This Fund
S&P 500
This Quarter
Est. Return
+6.77%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$914M
AUM Growth
+$67.7M
(+8%)
Cap. Flow
+$17.1M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
31.66%
Holding
292
New
16
Increased
25
Reduced
16
Closed
12
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$6.32M |
| 2 |
JPMorgan Chase
JPM
|
+$3.57M |
| 3 |
Pfizer
PFE
|
+$3.16M |
| 4 |
GSK
GSK
|
+$2.84M |
| 5 |
Nordson
NDSN
|
+$528K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLC
Clarcor
CLC
|
+$1.39M |
| 2 |
CLNY
Colony Capital, Inc.
CLNY
|
+$454K |
| 3 |
STJ
St Jude Medical
STJ
|
+$393K |
| 4 |
Idexx Laboratories
IDXX
|
+$389K |
| 5 |
Portland General Electric
POR
|
+$334K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.03% |
| 2 | Technology | 16.72% |
| 3 | Healthcare | 13.67% |
| 4 | Communication Services | 12.36% |
| 5 | Financials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
EVHC
251
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $241K | 0.03% |
3,933
| – | – |
2016 Q1
4 quarters
|
|
252
Southern Copper
SCCO
$169B
| $241K | 0.03% |
7,334
| – | – |
2016 Q4
1 quarter
|
|
253
United Natural Foods
UNFI
$2.88B
| $238K | 0.03% |
5,508
| – | – |
2016 Q1
4 quarters
|
|
254
Oceaneering
OII
$4.36B
| $238K | 0.03% |
8,783
| – | – |
2016 Q1
4 quarters
|
|
255
DELISTED
Dermira, Inc.
DERM
| $236K | 0.03% |
6,914
| – | – |
2016 Q2
3 quarters
|
|
256
Darling Ingredients
DAR
$9.68B
| $234K | 0.03% |
16,116
| – | – |
2016 Q1
4 quarters
|
|
257
Hain Celestial
HAIN
$21.5M
| $231K | 0.03% |
6,209
| – | – |
2016 Q1
4 quarters
|
|
258
DELISTED
Nordstrom
JWN
| $228K | 0.03% |
4,904
| – | – |
2016 Q2
3 quarters
|
|
259
Pebblebrook Hotel Trust
PEB
$2.2B
| $228K | 0.02% |
7,793
| – | – |
2016 Q1
4 quarters
|
|
|
PNK
260
DELISTED
Pinnacle Entertainment Inc.
PNK
| $226K | 0.02% |
+11,580
| New | +$191K |
2017 Q1
0 quarters
|
|
261
DELISTED
Radius Health, Inc.
RDUS
| $221K | 0.02% |
+5,718
| New | +$240K |
2017 Q1
0 quarters
|
|
|
GWR
262
DELISTED
Genesee & Wyoming Inc.
GWR
| $219K | 0.02% |
+3,227
| New | +$233K |
2017 Q1
0 quarters
|
|
|
FOE
263
DELISTED
Ferro Corporation
FOE
| $217K | 0.02% |
14,260
| – | – |
2016 Q1
4 quarters
|
|
264
Chatham Lodging
CLDT
$654M
| $213K | 0.02% |
10,784
| – | – |
2016 Q1
4 quarters
|
|
|
PDCE
265
DELISTED
PDC Energy, Inc.
PDCE
| $211K | 0.02% |
3,378
| – | – |
2016 Q3
2 quarters
|
|
266
Emerson Electric
EMR
$90.1B
| $210K | 0.02% |
+3,500
| New | +$209K |
2017 Q1
0 quarters
|
|
267
Itaú Unibanco
ITUB
$104B
| $204K | 0.02% |
34,876
| – | – |
2016 Q1
4 quarters
|
|
268
Equinor
EQNR
$111B
| $202K | 0.02% |
11,775
| – | – |
2016 Q4
1 quarter
|
|
269
Dr. Reddy's Laboratories
RDY
$10.9B
| $202K | 0.02% |
25,160
| – | – |
2016 Q1
4 quarters
|
|
|
ZOES
270
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $191K | 0.02% |
10,307
| – | – |
2016 Q4
1 quarter
|
|
271
Lloyds Banking Group
LYG
$78.5B
| $173K | 0.02% |
50,997
| – | – |
2016 Q1
4 quarters
|
|
272
Banco Bradesco
BBD
$44.3B
| $168K | 0.02% |
+31,703
| New | +$167K |
2017 Q1
0 quarters
|
|
273
ICICI Bank
IBN
$108B
| $151K | 0.02% |
19,361
| – | – |
2016 Q1
4 quarters
|
|
274
Adecoagro
AGRO
$1.45B
| $142K | 0.02% |
12,430
| – | – |
2016 Q1
4 quarters
|
|
275
Cenovus Energy
CVE
$60.7B
| $142K | 0.02% |
12,592
| – | – |
2016 Q3
2 quarters
|
|
Similar funds
Henshaw Capital's Q1 2017 Portfolio in Review
As of Q1 2017, Henshaw Capital held 292 positions worth $914M, up 8% from $847M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Henshaw Capital's Q1 2017 filing shows 16 new, 25 increased, 16 reduced and 12 closed positions. Its largest new stake was Nordson: 4,459 shares worth $548K. The largest sale was Clarcor, an estimated $1.39M.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Henshaw Capital's largest Q1 2017 buy was Nordson: 4,459 shares worth $548K.
- Henshaw Capital added most to Vanguard FTSE Emerging Markets ETF in Q1 2017, an estimated $6.32M increase.
- Henshaw Capital's biggest Q1 2017 reduction was Idexx Laboratories, cutting an estimated $389K.
- Henshaw Capital fully exited Clarcor in Q1 2017, selling an estimated $1.39M.
- Henshaw Capital's ten largest holdings make up 32% of its $914M portfolio in Q1 2017.
- Henshaw Capital opened 16 new positions and closed 12 in Q1 2017.
- Henshaw Capital's portfolio value rose 8% quarter-over-quarter to $914M.
Based on Henshaw Capital's 13F filing for Q1 2017, filed 28 May 2026.